Melanotic Xp11 translocation renal cancer

From Libre Pathology
Revision as of 05:13, 2 January 2018 by Michael (talk | contribs) (more)
Jump to navigation Jump to search

Melanotic Xp11 translocation renal cancer is a very rare kidney tumour that is evolving as an entity.[1]

Melanotic Xp11 translocation renal cancer
Diagnosis in short
Molecular Xp11 translocation
Grossing notes partial nephrectomy grossing, Total nephrectomy for tumour grossing
Site kidney - see kidney tumours

Prevalence case reports
Prognosis unknown
Clin. DDx other renal tumours
Treatment excision

General

  • Evolving entity.[2][1]
  • Very rare.

Microscopic

Features:

DDx:

Images

IHC

  • TFE3 +ve.
  • Keratin -ve.

Molecular

  • TFE3 rearrangement.

See also

References

  1. 1.0 1.1 Rao, Q.; Shen, Q.; Xia, QY.; Wang, ZY.; Liu, B.; Shi, SS.; Shi, QL.; Yin, HL. et al. (Sep 2015). "PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.". Am J Surg Pathol 39 (9): 1181-96. doi:10.1097/PAS.0000000000000502. PMID 26274027.
  2. Argani, P.; Aulmann, S.; Karanjawala, Z.; Fraser, RB.; Ladanyi, M.; Rodriguez, MM. (Apr 2009). "Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.". Am J Surg Pathol 33 (4): 609-19. doi:10.1097/PAS.0b013e31818fbdff. PMID 19065101.